ONCOGENEX PHARMACEUTICALS IN's ticker is OGXI and the CUSIP is 68230A106. A total of 69 filers reported holding ONCOGENEX PHARMACEUTICALS IN in Q2 2014. The put-call ratio across all filers is 4.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $2,000 | -77.8% | 6,600 | -68.7% | 0.00% | -100.0% |
| Q1 2017 | $9,000 | +125.0% | 21,100 | +145.3% | 0.00% | – |
| Q4 2016 | $4,000 | +33.3% | 8,600 | +30.3% | 0.00% | – |
| Q3 2016 | $3,000 | -40.0% | 6,600 | +43.5% | 0.00% | -100.0% |
| Q2 2016 | $5,000 | -54.5% | 4,600 | -0.7% | 0.00% | -50.0% |
| Q4 2014 | $11,000 | -8.3% | 4,633 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $12,000 | -29.4% | 4,633 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $17,000 | -79.0% | 4,633 | -32.9% | 0.00% | -81.8% |
| Q1 2014 | $81,000 | +376.5% | 6,900 | +246.4% | 0.01% | +266.7% |
| Q4 2013 | $17,000 | -5.6% | 1,992 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $18,000 | -63.3% | 1,992 | -60.2% | 0.00% | -72.7% |
| Q2 2013 | $49,000 | – | 5,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|